The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive intervention aiming to reach early and persistent low disease activity and remission. New drugs have improved the therapeutic armamentarium of rheumatologists, providing new options for patients. Beyond these innovations, new evidence has improved the safety of therapies and provided tools for the optimisation of long-term management of RA. This paper reviews the most relevant studies published over the last year in the field of treatment of RA.
Bortoluzzi, A., Furini, F., Generali, E., Silvagni, E., Luciano, N., Scire, C. (2018). One year in review 2018: Novelties in the treatment of rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 36(3), 0347-0361.
One year in review 2018: Novelties in the treatment of rheumatoid arthritis
Scire C. A.Ultimo
2018
Abstract
The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive intervention aiming to reach early and persistent low disease activity and remission. New drugs have improved the therapeutic armamentarium of rheumatologists, providing new options for patients. Beyond these innovations, new evidence has improved the safety of therapies and provided tools for the optimisation of long-term management of RA. This paper reviews the most relevant studies published over the last year in the field of treatment of RA.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Bortoluzzi et al. - 2018 - One year in review 2018 novelties in the treatmen.pdf
accesso aperto
Descrizione: articolo principale - free to view
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Dimensione
291.2 kB
Formato
Adobe PDF
|
291.2 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
